- Home
- PRFX vs SXTC Comparison
PRFX vs SXTC Comparison
Compare PRFX & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRFX | SXTC |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.8M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PRFX | SXTC |
|---|---|---|
| Price | $1.53 | $1.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 33.9K | 11.5K |
| Earning Date | 03-26-2026 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.58 | $0.03 |
| 52 Week High | $3.71 | $6.98 |
Technical Indicators
Market Signals| Indicator | PRFX | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 26.03 | 43.87 |
| Support Level | $1.26 | $1.19 |
| Resistance Level | $1.58 | $1.80 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 26.43 | 32.04 |
Price Performance
Historical ComparisonAbout PRFX PainReform Ltd.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasise reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the Company's lead product, is based on the local anaesthetic ropivacaine and targets the postoperative pain relief market.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.